Difference between revisions of "Profiles"
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
| − | ==Stage 3: Technically Confirmed== | + | ===Stage 3: Technically Confirmed=== |
* [[Media:QIBA FDG-PET Profile v104 06Nov2013.doc|FDG-PET/CT for Response to Cancer Therapy 2013-11-06]] ? | * [[Media:QIBA FDG-PET Profile v104 06Nov2013.doc|FDG-PET/CT for Response to Cancer Therapy 2013-11-06]] ? | ||
| − | ==Stage 2: Publicly Reviewed== | + | ===Stage 2: Publicly Reviewed=== |
* | * | ||
| − | ==Stage 1: Public Comment== | + | ===Stage 1: Public Comment=== |
* [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'') | * [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'') | ||
* [[Media:2011 07 28 Profile CT Advanced Disease V2 0f.pdf|CT Volumetry for Advanced Disease 2011-07-08]] (''Public Comment ended Sept 2011'') | * [[Media:2011 07 28 Profile CT Advanced Disease V2 0f.pdf|CT Volumetry for Advanced Disease 2011-07-08]] (''Public Comment ended Sept 2011'') | ||
| Line 18: | Line 18: | ||
*[[Work Product for Review]] | *[[Work Product for Review]] | ||
*[[QIBA Profile Template]] - <may provide useful explanations of what the structure/format/wording of profiles mean> | *[[QIBA Profile Template]] - <may provide useful explanations of what the structure/format/wording of profiles mean> | ||
| − | *[[Committees]] - <text about in process drafts being available on the page of the Biomarker Cmte that is developing it> | + | *[[Committees]] - host <text about in process drafts being available on the page of the Biomarker Cmte that is developing it> |
| − | *[[Conformance]] - <discussion of how sites and products claim conformance to a profile> | + | *[[Profile Conformance]] - <discussion of how sites and products claim conformance to a profile> |
Revision as of 22:54, 4 May 2016
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed
Stage 2: Publicly Reviewed
Stage 1: Public Comment
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
- CT Volumetry for Advanced Disease 2011-07-08 (Public Comment ended Sept 2011)
See Also
- How to use QIBA Profiles
- Work Product for Review
- QIBA Profile Template - <may provide useful explanations of what the structure/format/wording of profiles mean>
- Committees - host <text about in process drafts being available on the page of the Biomarker Cmte that is developing it>
- Profile Conformance - <discussion of how sites and products claim conformance to a profile>